📰 Key Activities News
Page 2 - Key Activities News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Key Activities. Real-time updates on events, politics, business and more.
October 6, 2022
UW Division of Extension Community Food Systems Program webinar for food entrepreneurs, 10 am-4 pm, 11/14-15. $65. RSVP for link by 10/31.
August 12, 2022
Advanced RG6501 (OpRegen®) Development in Partnership with Roche and GenentechPublished OPC1 Phase 1/2a Clinical Study Results in Journal of Neurosurgery: SpineCompleted Key Activities to Support Planned Regulatory Interactions for OPC1 and VAC2Expanded Collaboration with Advanced BioMatrix for HyStem® Cell Drug Del...
May 13, 2022
/PRNewswire/ -- The "AI in Bio Pharmaceuticals" report has been added to ResearchAndMarkets.coms offering. This report forecasts a considerable trend for "AI...
February 11, 2022
SAN DIEGO, Feb. 11, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter ...
December 2, 2021
[center][img]https://i.imgur.com/srEJxia.png[/img][/center][center][b]Business Model Innovation for Management Consultants[/b][/center] Duration: 4h 44m | .MP4 1280x720, 30 fps(r) | AAC, 44100 Hz, 2ch | 1.46 GB Genre: eLearning | Language: English A practical guide on how to change & innovate...
November 1, 2021
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the third quarter ended September 30, 2021. "Our third...
May 10, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update Catalyst Pharmaceuticals, Inc.May 10, 2021 GMT -Firdapse® Q1 2021 Net Revenues of $30.2 Million -First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income of $11.6 Million -Recently Received Orphan Drug Designation for Firdapse® in Japan -$143.3 Million in Cash and Investments and no Fu...